Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany

Journal of Medical Microbiology

Volumn 58, Issue 2, 2009, Pages 222-227

  Asmah, Nadine ^a   Eberspächer, Bettina ^b   Regnath, Thomas ^c   Arvand, Mardjan ^d  

^a Hygiene Institut   (Germany)

^b Vivantes   (Germany)

^c Labor Enders und Partner   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; RNA 16S; VANCOMYCIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CLUSTER ANALYSIS; DISK DIFFUSION; ERMA GENE; ERMB GENE; GENETIC HETEROGENEITY; GERMANY; MEFA GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS ANGINOSUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CLINDAMYCIN; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; GENOTYPE; GERMANY; HUMANS; LINCOSAMIDES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS ANGINOSUS; STREPTOGRAMIN B;

EID: 59949096195     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.001560-0     Document Type: Article

References (24)

1. Aracil, B., Gomez-Garces, J. L. & Alos, J. I. (1999). A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins. J Antimicrob Chemother 43, 399-402.
2. Arvand, M., Hoeck, M., Hahn, H. & Wagner, J. (2000). Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. J Antimicrob Chemother 46, 621-624.
3. Bartie, K. L., Wilson, M. J., Williams, D. W. & Lewis, M. A. (2000). Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis. J Clin Microbiol 38, 2141-2149.
4. Clarridge, J. E., III, Attorri, S., Musher, D. M., Hebert, J. & Dunbar, S. (2001). Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group'') are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32, 1511-1515.
5. Clarridge, J. E., III, Osting, C., Jalali, M., Osborne, J. & Waddington, M. (1999). Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a Veterans Administration hospital population. J Clin Microbiol 37, 3681-3687.
6. Clinical and Laboratory Standards Institute (2008). Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement M100-S13 28.
7. Facklam, R. (2002). What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15, 613-630.
8. File, T. M., Jr (2006). Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin Microbiol Infect 12, 31-41.
9. Jacobs, J. A. & Stobberingh, E. E. (1996). In vitro antimicrobial susceptibility of the "Streptococcus milleri" group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 37, 371-375.
10. Laupland, K. B., Ross, T., Church, D. L. & Gregson, D. B. (2006). Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 12, 224-230.
11. Limia, A., Jiménez, M. L., Alarcón, T. & López-Brea, M. (1999). Five- year analysis of antimicrobial susceptibility of the Streptococcus milleri group. Eur J Clin Microbiol Infect Dis 18, 440-444.
12. Livermore, D. M. (2000). Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16, S3-S10.
13. Morosini, M. I., Cantón, R., Loza, E., del Campo, R., Almaraz, F. & Baquero, F. (2003). Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J Antimicrob Chemother 52, 50-55.
14. Deutsches Institut fUr Normung e. V. (1999). Normenausschuss Medizin in DIN. Susceptibility testing of pathogens to antimicrobial agents, part 4. DIN 589-4.
15. Olsson-Liljequist, B., Larsson, P., Walder, M. & Miörner, H. (1997). Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl 105, 13-23.
16. Pallares, R., Viladrich, P. F., Linares, J., Cabellos, C. & Guidol, F. (1998). Impact of antibiotic resistance on chemotherapy for pneumococcal infections. Microb Drug Resist 4, 339-347.
17. Rashid, R. M., Salah, W. & Parada, J. P. (2007). 'Streptococcus milleri aortic valve endocarditis and hepatic abscess. J Med Microbiol 56, 280-282.
18. Reinert, R. R., Al-Lahham, A., Lemperle, M., Tenholte, C., Briefs, C., Haupts, S., Gerards, H. H. & Lütticken, R. (2002). Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother 49, 61-68.
19. Schoening, T. E., Wagner, J. & Arvand, M. (2005). Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany. Clin Microbiol Infect 11, 579-582.
20. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32, 885-891.
21. Seppälä, H., Haanperä, M., Al-Juhaish, M., Järvinen, H., Jalava, J. & Huovinen, P. (2003). Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 52, 636-644.
22. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996a). Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40, 2562-2566.
23. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996b). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40, 1817-1824.
24. Tracy, M., Wanahita, A., Shuhatovich, Y., Goldsmith, E. A., Clarridge, J. E., III & Musher, D. M. (2001). Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother 45, 1511-1514.